AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Avoca Listed in the 2015 Inc. 5000

The Avoca Group Listed in Inc. Magazine’s 34th Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000

The Avoca Group Ranks No. 2327 on the 2015 Inc. 5000 with Three-Year Sales Growth of 165%

NEW YORK, August 19, 2015Inc. magazine ranked The Avoca Group, No. 2327 on its 34th annual

Inc. 5000, an exclusive ranking of the nation’s fastest-growing private companies. Avoca’s three-year sales growth of 165% earned the company its spot in the top 50% of the list.

“It is truly an honor to be included in the 2015 Inc. 5000 list of fastest-growing US companies.  The most rewarding aspect of Avoca’s growth has been the close relationships that we have formed with our clients.  We have worked with the best and brightest people in the pharmaceutical industry and have been in partnership with the industry’s top companies for many years.  We have grown as an organization as the industry has evolved and changed and as the needs of our clients have changed.” said Avoca CEO, Patricia Leuchten. “Avoca has been a catalyst for industry collaboration, and we are making a difference through our work.  Being included on the Inc. 5000 list with other companies that are doing great things is very gratifying.”

The Avoca Group Inc. is an industry authority transforming the clinical research process for outsourced clinical trials. Founded in 1999, The Avoca Group provides pharmaceutical research and consulting services and specializes in the development of innovative solutions to address the challenges of managing quality in outsourced clinical trials. To accelerate the development of leading practices and industry standards for proactive quality management and risk mitigation in clinical research, Avoca founded The Avoca Quality Consortium in 2011. The Consortium brings together professionals from over 45 member pharmaceutical and biotechnology companies and clinical service providers who work together to improve the quality and outcomes of outsourced clinical trials.

“The story of this year’s Inc. 5000 is the story of great leadership. In an incredibly competitive business landscape, it takes something extraordinary to take your company to the top,” says Inc. President and Editor-In-Chief, Eric Schurenberg. “You have to remember that the average company on the Inc. 5000 grew nearly six-fold since 2012.  Business owners don’t achieve that kind of success by accident.”

The Inc. 5000 is a prestigious ranking of U.S.-based, privately held, for profit and independent companies, based on percentage revenue growth when comparing 2011 to 2014. For the full list of this year’s Inc. 5000 winners, visit: